Authors: Golden-Mason, L Curry, MP Nolan, N Traynor, O McEntee, G Kelly, J Hegarty, JE O'Farrelly, C

Citation: L. Golden-mason et al., Differential expression of lymphoid and myeloid markers on differentiatinghematopoietic stem cells in normal and tumor-bearing adult human liver, HEPATOLOGY, 31(6), 2000, pp. 1251-1256

Authors: Curry, MP Golden-Mason, L Nolan, N Parfrey, NA Hegarty, JE O'Farrelly, C

Citation: Mp. Curry et al., Expansion of peripheral blood CD5(+) B cells is associated with mild disease in chronic hepatitis C virus infection, J HEPATOL, 32(1), 2000, pp. 121-125

Authors: McKiernan, SM Hagan, R Curry, M McDonald, GSA Nolan, N Crowley, J Hegarty, J Lawlor, E Kelleher, D

Citation: Sm. Mckiernan et al., The MHC is a major determinant of viral status, but not fibrotic stage, inindividuals infected with hepatitis C, GASTROENTY, 118(6), 2000, pp. 1124-1130

Authors: Greaney, TV Nolan, N Malone, DE

Citation: Tv. Greaney et al., Multiple gastric polyps in familial amyloid polyneuropathy, ABDOM IMAG, 24(3), 1999, pp. 220-222

Authors: Nishikibe, M Ohta, H Okada, M Ishikawa, K Hayama, T Fukuroda, T Noguchi, K Saito, M Kanoh, T Ozaki, S Kamei, T Hara, K William, D Kivlighn, S Krause, S Gabel, R Zingaro, G Nolan, N O'Brien, J Clayton, F Lynch, J Pettibone, D Siegl, P

Citation: M. Nishikibe et al., Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist, J PHARM EXP, 289(3), 1999, pp. 1262-1270